Skip to search formSkip to main contentSkip to account menu

Carbon C 14 Vemurafenib

Known as: 14 C-labeled Vemurafenib 
A radioconjugate composed of vemurafenib, an ATP-competitive, small-molecule inhibitor of BRAF(V600E) kinase, labeled with the radioisotope carbon C… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Vemurafenib is a BRAF kinase inhibitor indicated for the treatment of patients with BRAFV600 mutation–positive unresectable or…